The Sofia SARS Antigen Fluorescent Immunoassay (FIA) uses advanced immunofluorescence-based lateral flow technology in a sandwich design for qualitative detection of nucleocapsid protein from SARS-CoV-2. The Sofia SARS Antigen FIA, with the Sofia 2 and Sofia analyzers, provides automated and objective results in 15 minutes, allowing for testing of patients suspected of COVID-19/2019-nCoV in near-patient testing environments.
• An antigen is a molecule or structure present on the outside of a pathogen.
• Antigen tests are typically used for early identification of an active infection in symptomatic patients.
• These tests identify the virus through detection of nucleoproteins, similar to influenza tests.
• Viral antigens can often be detected in samples taken from nasal passages and from the throat.
• The Centers for Disease Control and Prevention recommends using a test that detects the SARS-CoV-2 virus, such as one that checks respiratory samples, to test for active infection.
When fast action and trusted information matter more than ever, we are committed to aiding in the response. SARS-CoV-2 RNA (COVID-19), Qualitative NAAT, Test Code 39448 The RNA test is a qualitative multi-target molecular diagnostics test that aids in the detection of COVID19. This test is intended to be performed on respiratory specimens collected from individuals who meet the Centers for Disease Control and Prevention (CDC) clinical and/or epidemiological criteria for COVID19 testing. For details visit: https://www.cdc.gov/coronavirus/2019-ncov/hcp/index.html
SARS-CoV-2 RNA (COVID-19), Qualitative NAAT - The SARS-CoV-2 RNA (COVID-19), Nucleicacid Amplification Test (NAAT) is a qualitative multi-target molecular diagnostics test that aids in the detection of COVID-19. This test is intended to be performed on respiratory specimens collected
from individuals who meet the Centers for Diseases Control and Prevention (CDC) clinical and/or Epidemiological criteria for COVID-19 testing.
For details visit: https://www.cdc.gov/coronavirus/2019-ncov/hcp/index.html
The COVID-19 Antibody Immunoassay is a blood test that is designed to detect the human antibodies lgG & lgM.
Upon infection with the SARS-CoV-2 virus, the patient's immune system fights the virus by producing specialized immune cells known as antibodies. The two major types of antibodies employed in the fight against viruses of this type are IgM and IgG.
• lgM is a class of antibody that appears early after an infection (as early as 3-5 days). lgM is the body's first line of defense against a foreign invader.
• lgG is another class of antibody that appears later and gradually replaces the lgM antibodies. Typically, lgG antibodies appear in the blood circulation within 2-4 weeks after initial infection.
The presence of SARS-CoV-2-specific lgM and/or lgG antibodies is a strong indication that the patient has been infected with the SARS-CoV-2 virus and may suggest non-susceptibility in the future/functional immunity
Fill out the form below to speak with a COVID-19 ANTIBODY BLOOD TEST EXPERT
Keep your employees and community safe
ARCpoint Labs of Tampa Coronavirus Antibody Test can help you make informed decisions regarding your staff’s return to work or safe interaction with others. This is especially important with essential employees such as first responders, medical professionals, or other essential staff.
If you are interested in testing your employees, we're here for you! With onsite testing available, we're able to work within your schedule to test your employees so everyone can work safely.
Schedule your appointment
Come to your ARC Point Labs and get your sample collected
Get results via a secure email in about 48 hours
Learn More About Our Testing Services
© 2020, ARCPOINT LABS OF TAMPA
Site Disclaimer: Any and all content provided on this Website or the Services, including links to other websites is provided for information and educational purposes only and does not constitute advice, recommendation or support of such content or website. Florida Medical Labs DBA ARCpoint Labs of Tampa makes every effort to provide true and accurate content on its Website. However, Florida Medical Labs DBA ARCpoint Labs of Tampa provides no warranty, express or implied, of the accuracy, completeness, timeliness, or applicability of such content. Florida Medical Labs DBA ARCpoint Labs of Tampa accepts no responsibility for and excludes all liability in connection with information provided on Florida Medical Labs DBA ARCpoint Labs of Tampa’s website, including but not limited to any liability for errors, inaccuracies or omissions.